Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.

Conway SM, Puttick D, Russell S, Potter D, Roitman MF, Chartoff EH.

Neuropharmacology. 2019 Mar 1;146:231-241. doi: 10.1016/j.neuropharm.2018.12.002. Epub 2018 Dec 5.

PMID:
30528327
2.

Social defeat disrupts reward learning and potentiates striatal nociceptin/orphanin FQ mRNA in rats.

Der-Avakian A, D'Souza MS, Potter DN, Chartoff EH, Carlezon WA Jr, Pizzagalli DA, Markou A.

Psychopharmacology (Berl). 2017 May;234(9-10):1603-1614. doi: 10.1007/s00213-017-4584-y. Epub 2017 Mar 9.

3.

Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Russell SE, Puttick DJ, Sawyer AM, Potter DN, Mague S, Carlezon WA Jr, Chartoff EH.

J Neurosci. 2016 May 25;36(21):5748-62. doi: 10.1523/JNEUROSCI.2875-12.2016.

4.

Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.

Chartoff EH, Mavrikaki M.

Front Neurosci. 2015 Dec 16;9:466. doi: 10.3389/fnins.2015.00466. eCollection 2015. Review.

5.

Translational Studies of Sex Differences in Sensitivity to Opioid Addiction.

Chartoff EH, McHugh RK.

Neuropsychopharmacology. 2016 Jan;41(1):383-4. doi: 10.1038/npp.2015.272. Review. No abstract available.

6.

Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.

Chartoff EH, Ebner SR, Sparrow A, Potter D, Baker PM, Ragozzino ME, Roitman MF.

Neuropsychopharmacology. 2016 Mar;41(4):989-1002. doi: 10.1038/npp.2015.226. Epub 2015 Aug 4.

7.

The Aversive Agent Lithium Chloride Suppresses Phasic Dopamine Release Through Central GLP-1 Receptors.

Fortin SM, Chartoff EH, Roitman MF.

Neuropsychopharmacology. 2016 Feb;41(3):906-15. doi: 10.1038/npp.2015.220. Epub 2015 Jul 27.

8.

Sprouty2 in the dorsal hippocampus regulates neurogenesis and stress responsiveness in rats.

Dow AL, Lin TV, Chartoff EH, Potter D, McPhie DL, Van't Veer AV, Knoll AT, Lee KN, Neve RL, Patel TB, Ongur D, Cohen BM, Carlezon WA Jr.

PLoS One. 2015 Mar 30;10(3):e0120693. doi: 10.1371/journal.pone.0120693. eCollection 2015.

9.

Social defeat stress-induced sensitization and escalated cocaine self-administration: the role of ERK signaling in the rat ventral tegmental area.

Yap JJ, Chartoff EH, Holly EN, Potter DN, Carlezon WA Jr, Miczek KA.

Psychopharmacology (Berl). 2015 May;232(9):1555-69. doi: 10.1007/s00213-014-3796-7. Epub 2014 Nov 6.

10.

Drug withdrawal conceptualized as a stressor.

Chartoff EH, Carlezon WA Jr.

Behav Pharmacol. 2014 Sep;25(5-6):473-92. doi: 10.1097/FBP.0000000000000080. Review.

11.

Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats.

Pravetoni M, Pentel PR, Potter DN, Chartoff EH, Tally L, LeSage MG.

PLoS One. 2014 Jul 15;9(7):e101807. doi: 10.1371/journal.pone.0101807. eCollection 2014.

12.

It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.

Chartoff EH, Connery HS.

Front Pharmacol. 2014 May 27;5:116. doi: 10.3389/fphar.2014.00116. eCollection 2014. Review.

13.

Early life stress disrupts social behavior and prefrontal cortex parvalbumin interneurons at an earlier time-point in females than in males.

Holland FH, Ganguly P, Potter DN, Chartoff EH, Brenhouse HC.

Neurosci Lett. 2014 Apr 30;566:131-6. doi: 10.1016/j.neulet.2014.02.023. Epub 2014 Feb 22.

14.

Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats.

Russell SE, Rachlin AB, Smith KL, Muschamp J, Berry L, Zhao Z, Chartoff EH.

Biol Psychiatry. 2014 Aug 1;76(3):213-22. doi: 10.1016/j.biopsych.2013.07.042. Epub 2013 Oct 3.

15.

Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression.

Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF.

PLoS One. 2013;8(3):e58251. doi: 10.1371/journal.pone.0058251. Epub 2013 Mar 13.

16.

Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity.

Van't Veer A, Bechtholt AJ, Onvani S, Potter D, Wang Y, Liu-Chen LY, Schütz G, Chartoff EH, Rudolph U, Cohen BM, Carlezon WA Jr.

Neuropsychopharmacology. 2013 Jul;38(8):1585-97. doi: 10.1038/npp.2013.58. Epub 2013 Feb 27.

17.

Detection of intranasally delivered bone marrow-derived mesenchymal stromal cells in the lesioned mouse brain: a cautionary report.

Chartoff EH, Damez-Werno D, Sonntag KC, Hassinger L, Kaufmann DE, Peterson J, McPhie D, Cataldo AM, Cohen BM.

Stem Cells Int. 2011;2011:586586. doi: 10.4061/2011/586586. Epub 2011 Nov 15.

18.

Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.

Potter DN, Damez-Werno D, Carlezon WA Jr, Cohen BM, Chartoff EH.

Biol Psychiatry. 2011 Oct 15;70(8):744-53. doi: 10.1016/j.biopsych.2011.05.021. Epub 2011 Jul 14.

19.

Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens.

Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH.

Psychopharmacology (Berl). 2010 Jun;210(2):241-52. doi: 10.1007/s00213-010-1836-5. Epub 2010 Apr 7.

20.

Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.

Chartoff EH, Barhight MF, Mague SD, Sawyer AM, Carlezon WA Jr.

Psychopharmacology (Berl). 2009 Jun;204(2):227-39. doi: 10.1007/s00213-008-1454-7. Epub 2009 Jan 16.

21.

Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue.

Chartoff EH, Papadopoulou M, MacDonald ML, Parsegian A, Potter D, Konradi C, Carlezon WA Jr.

Mol Pharmacol. 2009 Mar;75(3):704-12. doi: 10.1124/mol.108.051417. Epub 2008 Dec 23.

22.

The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

Tomasiewicz HC, Todtenkopf MS, Chartoff EH, Cohen BM, Carlezon WA Jr.

Biol Psychiatry. 2008 Dec 1;64(11):982-8. doi: 10.1016/j.biopsych.2008.05.029. Epub 2008 Jul 17.

23.

Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats.

Chartoff EH, Potter D, Damez-Werno D, Cohen BM, Carlezon WA Jr.

Neuropsychopharmacology. 2008 Oct;33(11):2676-87. doi: 10.1038/sj.npp.1301659. Epub 2008 Jan 9.

24.

Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation.

Carlezon WA Jr, Chartoff EH.

Nat Protoc. 2007;2(11):2987-95.

PMID:
18007634
25.

Extreme chipping: addiction to a high-fat diet?

Carlezon WA Jr, Chartoff EH.

Biol Psychiatry. 2007 May 1;61(9):1019-20. No abstract available.

PMID:
17434011
26.

Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal.

Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr.

J Neurosci. 2006 Jun 14;26(24):6450-7.

27.
28.

LTP in the lateral amygdala during cocaine withdrawal.

Goussakov I, Chartoff EH, Tsvetkov E, Gerety LP, Meloni EG, Carlezon WA Jr, Bolshakov VY.

Eur J Neurosci. 2006 Jan;23(1):239-50.

PMID:
16420433
29.

CREB gene transcription factors: role in molecular mechanisms of alcohol and drug addiction.

Pandey SC, Chartoff EH, Carlezon WA Jr, Zou J, Zhang H, Kreibich AS, Blendy JA, Crews FT.

Alcohol Clin Exp Res. 2005 Feb;29(2):176-84.

PMID:
15714041
30.

Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.

Chartoff EH, Heusner CL, Palmiter RD.

Neuropsychopharmacology. 2005 Jul;30(7):1324-33.

31.

Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.

Chartoff EH, Szczypka MS, Palmiter RD, Dorsa DM.

Brain Res. 2004 Oct 1;1022(1-2):71-80.

PMID:
15353215
32.

Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro.

Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA Jr.

Ann N Y Acad Sci. 2003 Nov;1003:368-71. No abstract available.

PMID:
14684463
34.

Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.

Chartoff EH, Marck BT, Matsumoto AM, Dorsa DM, Palmiter RD.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10451-6. Epub 2001 Aug 21.

35.

Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.

Chartoff EH, Ward RP, Dorsa DM.

J Pharmacol Exp Ther. 1999 Nov;291(2):531-7.

PMID:
10525068
36.

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice.

Adams MR, Brandon EP, Chartoff EH, Idzerda RL, Dorsa DM, McKnight GS.

Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12157-61.

37.

Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-beta responsive cells.

Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM.

Development. 1996 Jul;122(7):2099-108.

38.

Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.

Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM.

Genetics. 1995 Mar;139(3):1347-58.

Supplemental Content

Loading ...
Support Center